keyword
https://read.qxmd.com/read/38637262/randomized-clinical-trial-of-non-antibiotic-prophylaxis-with-d-mannose-plus-proanthocyanidins-vs-proanthocyanidins-alone-for-urinary-tract-infections-and-asymptomatic-bacteriuria-in-de-novo-kidney-transplant-recipients-the-manotras-study
#1
JOURNAL ARTICLE
Melissa Rau, Adrian Santelli, Sara Martí, María Isabel Díaz, Nuria Sabé, María Fiol, Luis Riera, Begoña Etcheverry, Sergi Codina, Ana Coloma, Anna Carreras-Salinas, Carmen Ardanuy, Josep M Cruzado, Edoardo Melilli
BACKGROUND: Studies analyzing non-antibiotic alternatives in kidney transplant UTI's are lacking. d-Mannose, a simple sugar, inhibits bacterial attachment to the urothelium, as does Proanthocyanidins; both could act as a synergic strategy preventing UTI; nonetheless their efficacy and safety have not been evaluated in kidney transplant population yet. METHODS: This is a pilot prospective, double-blind randomized trial. Sixty de novo kidney transplant recipients were randomized (1:1) to receive a prophylactic strategy based on a 24-h prolonged release formulation of d-Mannose plus Proanthocyanidins vs...
April 17, 2024: Nefrología
https://read.qxmd.com/read/38548564/the-paradigm-of-total-body-irradiation-in-acute-lymphoblastic-leukaemia-therapeutic-effectiveness-versus-the-challenges-of-toxicity
#2
JOURNAL ARTICLE
Carlos Echecopar, Ismael Del Val Rey, Víctor Galán-Gómez, Carlos González-Pérez, Yasmina Mozo Del Castillo, Berta González Martínez, Antonio Pérez-Martínez
INTRODUCTION: Total body irradiation (TBI) is part of the myeloablative conditioning for hematopoietic stem cell transplantation (HSCT) in malignant hematologic disorders. This therapy has recently shown improved survival in acute lymphoblastic leukemia (ALL) compared to chemotherapy-based regimens. However, side effects are a significant limitation, especially in the pediatric population. PATIENTS AND METHODS: We retrospectively analyzed the survival of patients with ALL who underwent an HSCT at a tertiary hospital between 1996 and 2009 (N = 69 HSCT in 57 patients)...
March 28, 2024: Anales de pediatría
https://read.qxmd.com/read/38326154/scedosporium-boydii-finding-in-an-immunocompromised-patient-and-review-of-the-literature
#3
JOURNAL ARTICLE
Silvana Ramadán, Hernán Dalmaso, Alicia Luque, Maximiliano Sortino, María Luján Cuestas, Katherine Hermida Alava, Diego Bertola, Lucía Bulacio
BACKGROUND: Scedosporiasis is an emerging mycosis that has gained importance in recent years due to its worldwide prevalence. It is caused by species of the Scedosporium apiospermum complex. These species can cause opportunistic infections in immunocompromised patients and, occasionally, in immunocompetent patients as well. The high intrinsic antifungal resistance make these infections difficult to manage. AIMS: The objective of this study was to interpret the mycological findings in a transplant patient, together with the images obtained in the radiological studies, in order to provide an early and effective antifungal therapy...
February 6, 2024: Revista Iberoamericana de Micología
https://read.qxmd.com/read/38253236/-translated-article-total-hip-arthroplasty-with-shelf-acetabuloplasty-in-dysplastic-coxarthrosis-mean-follow-up-of-7-years
#4
JOURNAL ARTICLE
E Barros-Prieto, E Noboa-Freile, C Peñaherrera-Carrillo, F Endara-Urresta, A Barros-Castro, N Vizuete-Cevallos, A Romero-Barros
Developmental dysplasia of the hip is the cause of approximately one third of secondary coxarthrosis. Anatomy alterations make it difficult to place a total hip prosthesis in its anatomical position and for it to be stable in the long term; there are several techniques to achieve this goal. In the present work, we used autograft of the femoral head (shelf graft or reinforced roof), to improve the coverage of the acetabular component with favourable results. Materials ad methods Sixteen cases were included in 14 patients with a diagnosis of developmental dysplasia of the hip (13 women and one man), the mean age was 44...
January 20, 2024: Revista Española de Cirugía Ortopédica y Traumatología
https://read.qxmd.com/read/38167647/ofatumumab-as-part-of-reduced-intensity-conditioning-in-high-risk-b-cell-lymphoma-patients-final-long-term-analysis-from-a-prospective-multicenter-phase-ii-trial
#5
MULTICENTER STUDY
Mónica Cabrero, Lucia López-Corral, Isidro Jarque, Fátima de la Cruz-Vicente, Estefanía Pérez-López, David Valcárcel, Jaime Sanz, Ildefonso Espigado, Guillermo Ortí, Carmen Martín-Calvo, Javier de la Serna, Dolores Caballero
Curative potential of allogeneic transplantation (AlloSCT) in high-risk non-Hodgkin lymphoma (NHL) could be enhanced by the integration of Ofatumumab (OFA), a 2nd generation anti-CD20 moAb, due to an antitumor effect and a role over graft-versus-host disease (GVHD). In this phase II trial (NCT01613300), we investigated safety and effectiveness of OFA-based reduced intensity conditioning (RIC). High-risk B-cell NHL patients with chemorrefractory disease or post-autologous SCT relapse were eligible. OFA was added to a standard RIC regimen...
March 2024: Bone Marrow Transplantation
https://read.qxmd.com/read/38097433/hepatitis-c-virus-positive-donors-in-hcv-negative-recipients-in-liver-transplantation-is-it-possible-in-mexico
#6
REVIEW
J A Torres-Díaz, E A Jasso-Baltazar, L Toapanta-Yanchapaxi, J Aguirre-Valadez, L Martínez-Matínez, A Sánchez-Cedillo, D Aguirre-Villareal, I García-Juárez
Hepatitis C virus (HCV) infection is a worldwide public health problem associated with significant morbidity and mortality. In the context of liver transplantation, the demand for organs continues to exceed the supply, prompting the consideration of using organs from HCV-positive donors in HCV-negative recipients. The introduction of direct-acting antivirals (DAAs), which have demonstrated great efficacy in eradicating the virus, has made transplantation of organs from donors with HCV infection possible. The present article provides a brief review of the current evidence on the use of organs from HCV-infected patients...
December 13, 2023: Revista de Gastroenterología de México
https://read.qxmd.com/read/37980212/secondary-hypogammaglobulinemia-in-adults-a-large-retrospective-cohort-study
#7
JOURNAL ARTICLE
Ernestina Angarola, Verónica Andrea Peuchot, Fernando Warley, Diana Inés Liberatore
BACKGROUND AND OBJECTIVE: IgG replacement therapy (IgG-RT) has radically changed the clinical evolution of primary immunodeficiencies, yet the information regarding secondary hypogammaglobulinemia (SHG) is insufficient or conflicting. We aim to describe clinical features, evolution and treatment of SHG patients in our center. METHODS: Dynamic retrospective cohort between January 2001 and July 2021 of adults with gamma globulin fraction <0.6g/dL in a serum protein electrophoresis and a coincident decrease of IgG levels - with a disease-related SHG or treatment that reduces serum immunoglobulins...
November 16, 2023: Medicina Clínica
https://read.qxmd.com/read/37957107/update-of-the-recommendations-on-the-management-of-the-sars-cov-2-coronavirus-pandemic-covid-19-in-kidney-transplant-patients
#8
REVIEW
Verónica López, Auxiliadora Mazuecos, Florentino Villanego, María López-Oliva, Angel Alonso, Isabel Beneyto, Marta Crespo, Carmen Díaz-Corte, Antonio Franco, Francisco González-Roncero, Luis Guirado, Carlos Jiménez, Javier Juega, Santiago Llorente, Javier Paul, Alberto Rodríguez-Benot, Juan Carlos Ruiz, Ana Sánchez-Fructuoso, Vicente Torregrosa, Sofía Zárraga, Emilio Rodrigo, Domingo Hernández
SARS-CoV-2 infection (COVID-19) has had a significant impact on transplant activity in our country. Mortality and the risk of complications associated with COVID-19 in kidney transplant recipients (KT) were expected to be higher due to their immunosuppressed condition and the frequent associated comorbidities. Since the beginning of the pandemic in March 2020 we have rapidly improved our knowledge about the epidemiology, clinical features and management of COVID-19 post-transplant, resulting in a better prognosis for our patients...
November 11, 2023: Nefrología
https://read.qxmd.com/read/37813738/lymphoproliferative-disorders-after-renal-transplantation-along-2-decades-a-large-longitudinal-study-of-21-546-recipients
#9
JOURNAL ARTICLE
Antonio Franco, Domingo Hernandez, Sofia Zarraga, Ana Sanchez Fructuoso, Marta Crespo, Auxiliadora Mazuecos, Carmen Diaz Corte, Alberto Rodriguez Benot, Juan Carlos Ruiz, Isabel Beneyto
INTRODUCTION: Post transplant lymphoproliferative disorders (PTLD) are heterogeneous lymphoid proliferations in recipients of solid organs which seem to be related to Epstein Barr Virus (EBV). The use of antilymphocyte antibodies, EBV seronegativity in the recipient,acute rejection and CMV infection have been identified as classical risk factors. MATERIAL Y METHODS: We have studied in a retrospective observational study, the incidence of PTLD in a period of 22 years, its relationship with EBV, presence of classical risk factors and outcome in 21546 simple adult renal transplant recipients from cadaveric and living donors, transplanted in 21 hospitals from 1990 to 2009...
2023: Nefrología
https://read.qxmd.com/read/37699225/sofosbuvir-plus-glecaprevir-pibrentasvir-as-salvage-therapy-after-liver-transplantation-in-ns5a-inhibitor-experienced-patients-a-case-series
#10
JOURNAL ARTICLE
Ignacio García-Juárez, Carlos Alonzo-García, Alan G Contreras, Fernanda Romero-Hernández, Maximiliano Servín-Rojas, Alfonso Fernández-Ramírez, Isaac Ruiz
BACKGROUND: Treatment of chronic hepatitis C virus (HCV) infection with direct-acting antivirals achieves a sustained virologic response rate higher than 95%. However, virologic failure remains a clinical challenge, and data on retreatment are limited, especially in special populations such as liver transplant (LT) recipients. OBJECTIVES: This study evaluated the sofosbuvir plus glecaprevir-pibrentasvir (GLE/PIB) regimen in LT recipients who had failed to a nonstructural protein 5A (NS5A) inhibitor-based regimen...
2023: Gaceta Médica de México
https://read.qxmd.com/read/37669570/-covid-19-in-transplant-recipients-multicentric-report-of-mexican-experience
#11
JOURNAL ARTICLE
Mónica Sánchez-Cárdenas, Enzo Vásquez-Jiménez, Ricardo I Velázquez-Silva, Mario Vilatobá-Chapa, Benjamín Gómez-Navarro, Lucio O Sánchez-Macías, José M Rodríguez-Chagolla, Ignacio García-Juárez, Severo M Abraham-Mancilla, Luis E Morales-Buenrostro, Idalia Parra-Ávila, César Flores-Gama
BACKGROUND: Solid Organ Transplant recipients (SOTR) appear to be at particular high risk for critical COVID-19 due to immunosuppressive drugs and comorbidities. We report the first description of clinical course and short-term outcomes of kidney and liver transplant recipients with confirmed COVID-19 in Mexico. The objective of this paper was evaluate the clinical course of transplant patients with COVID-19 infection. MATERIAL AND METHODS: We retrospectively evaluated SOTR (kidney and liver) over 18 years of age with confirmed diagnosis of COVID-19 from tertiary care centers in Mexico...
September 5, 2023: Archivos de Cardiología de México
https://read.qxmd.com/read/37661514/management-of-immunosuppressive-therapy-in-kidney-transplant-recipients-with-covid-19-a-multicentre-national-study-derived-from-the-spanish-society-of-nephrology-covid-registry
#12
JOURNAL ARTICLE
María O López-Oliva, Isabel Pérez-Flores, María Molina, María José Aladrén, Hernando Trujillo, Dolores Redondo-Pachón, Verónica López, Carme Facundo, Florentino Villanego, Marisa Rodríguez, Maria Carmen Ruiz, Paula Antón, Alba Rivas-Oural, Sheila Cabello, José Portolés, Lourdes de la Vara, Guadalupe Tabernero, Rosalía Valero, Cristina Galeano, Esperanza Moral, Ana Ventura, Armando Coca, Miguel Ángel Muñoz, Román Hernández-Gallego, Amir Shabaka, Gabriel Ledesma, Hanane Bouarich, María Ángeles Rodríguez, Lourdes Pérez Tamajón, Leónidas Cruzado, José Emilio Sánchez, Carlos Jiménez
INTRODUCTION: SARS CoV2 infection has had a major impact on renal transplant patients with a high mortality in the first months of the pandemic. Intentional reduction of immunosuppressive therapy has been postulated as one of the cornerstone in the management of the infection in the absence of targeted antiviral treatment. This has been modified according to the patient`s clinical situation and its effect on renal function or anti-HLA antibodies in the medium term has not been evaluated...
September 1, 2023: Nefrología
https://read.qxmd.com/read/37358099/-fecal-microbiota-transplantation-in-an-older-patient-with-clostridioides-difficile-recurrent-infection-report-of-one-case
#13
JOURNAL ARTICLE
Paulina Núñez, Rodrigo Quera, Christian Von Muhlenbrock, Alexandra Concha, Katherine Flores
Clostridioides difficile infection (CDI) is a major public health problem and responsible for significant morbidity and mortality. Eighty percent of CDIs occur in adults older than 65 years of age due to a decreased gastrointestinal microbial diversity, immunosenescence and frailty. Thus, the most reported risk factor for recurrent CDI is older age since nearly 60% of cases occur in individuals aged ≥ 65 years. Fecal microbiota transplantation (FMT) is a highly cost-effective alternative to antibiotic treatment for patients with recurrent CDI...
October 2022: Revista Médica de Chile
https://read.qxmd.com/read/37270055/total-hip-arthroplasty-with-shelf-acetabuloplasty-in-dysplastic-coxarthrosis-mean-follow-up-of-7-years
#14
JOURNAL ARTICLE
Barros-Prieto Edgar, Noboa-Freile Eduardo, Peñaherrera-Carrillo Carlos, Endara-Urresta Francisco, Barros-Castro Alejandro, Vizuete-Cevallos Nicolás, Romero-Barros Andrea
UNLABELLED: Developmental dysplasia of the hip (DDH) is the cause of approximately one third of secondary coxarthrosis. Anatomy alterations make it difficult to place a total hip prosthesis in its anatomical position and for it to be stable in the long term; there are several techniques to achieve this goal. In the present work we used autograft of the femoral head (shelf graft or reinforced roof), to improve the coverage of the acetabular component with favorable results. MATERIALS AND METHODS: 16 cases were included in 14 patients with a diagnosis of DDC (13 women and 1 man), the mean age was 44...
June 1, 2023: Revista Española de Cirugía Ortopédica y Traumatología
https://read.qxmd.com/read/37268500/changes-over-time-in-the-causes-of-death-with-a-functioning-graft-in-kidney-transplantation-recipients
#15
JOURNAL ARTICLE
Florentino Villanego, Luis Alberto Vigara, Verónica López, María Del Carmen de Gracia, Alberto Rodríguez-Benot, Gabriel Bernal, Pablo Castro, Auxiliadora Mazuecos
INTRODUCTION: Death with a functioning graft (DWFG) is the most frequent cause of loss of kidney transplantation (KT). OBJECTIVE: To analyze the evolution of the causes of DWFG and the frequency of the types of cancer causing DWFG. METHODS: Retrospective study of KT in Andalusia from 1984 to 2018. We analyzed the evolution according to eras (1984-1995; 1996-2007; 2008-2018) and according to post-transplant period (early death: first year post-KT; late death: after first year post-KT)...
2023: Nefrología
https://read.qxmd.com/read/36871623/early-readmissions-post-kidney-transplantation-lessons-learned
#16
JOURNAL ARTICLE
M Moein, I M Vlassis, L Kim, M Hanlon, R Saidi
INTRODUCTION: Kidney transplantation (KT) is the gold standard treatment for end-stage renal disease (ESRD) patients. Hospital readmissions post-transplant is a common complication and can be considered an indication of avoidable morbidity and hospital quality, and there is a significant correlation between EHR and adverse patient outcomes. This study aimed to assess the readmission rate following kidney transplants, the underlying causes, and possible ways to prevent it. MATERIAL AND METHODS: We retrospectively reviewed the medical records of recipients from January 2016 to December 2021 in a single center...
2023: Actas urologicas españolas
https://read.qxmd.com/read/36774246/impact-of-mobilization-in-patients-with-short-term-mechanical-circulatory-support-such-as-levitronix%C3%A2-centrimag-as-a-bridge-to-heart-transplantation
#17
JOURNAL ARTICLE
A Chicano-Corrales, J Bañeras-Rius, F de Frutos, J C Sánchez-Salado, A Ariza-Solé, A Blasco-Lucas, F Sbraga, C Díez-López, E Calvo-Barriuso, J Castillo García, C S Molina-Mazón, A López-López, I Tinoco-Amorós, A Abellán-García, J González-Costello
INTRODUCTION: Despite the benefits of mobilisation in the critical patient, the evidence in patients with Levitronix® CentriMag as a bridge to heart transplantation (HT) is scarce. The objective of this study is to analyze the impact of mobility on these patients. METHODS: Retrospective observational study of patients who received a HT with Levitronix® CentriMag admitted between 2010 and 2019 to a tertiary hospital. Degree of mobility and nutritional status were assessed at the time of HT...
2023: Enfermería intensiva
https://read.qxmd.com/read/36737368/faecal-microbiota-trasplant-current-status-and-perspectives-beyond-clostridioides-difficile-infection
#18
EDITORIAL
Rosa Del Campo, Javier Cobo
No abstract text is available yet for this article.
February 1, 2023: Enfermedades infecciosas y microbiologia clinica
https://read.qxmd.com/read/36681571/-faecal-microbiota-transplantation-is-a-simple-effective-and-safe-treatment-in-the-management-of-c-difficile-infection-in-daily-clinical-practice
#19
JOURNAL ARTICLE
Carlos Ferre-Aracil, Ismael El Hajra Martínez, María Isabel Vera Mendoza, Antonio Ramos Martínez, Elena Muñez Rubio, Ana Fernández-Cruz, Virginia Matallana Royo, Sarela García-Maseda, Isabel Sánchez Romero, Rocío Martínez Ruiz, José Luis Calleja Panero
INTRODUCTION: Faecal microbiota transplantation (FMT) is a treatment supported by wide scientific evidence and proved to be very effective in the management of Clostridioides difficile (CD) infection. The objective of this study is to analyze its effectiveness and safety in a real clinical practice setting. METHODS: Retrospective, single-center and descriptive observational study in which all FMT performed between May 2016 and December 2020 were included. Technical success was defined as the successful administration of the fecal preparation in the patient's gastrointestinal tract and clinical success the disappearance of diarrhea in the first 72 h after the procedure with no relapse within the following 8 weeks after the therapy was started...
January 19, 2023: Enfermedades infecciosas y microbiologia clinica
https://read.qxmd.com/read/36681519/impact-of-immunosuppression-regimen-on-covid-19-mortality-in-kidney-transplant-recipients-analysis-from-a-colombian-transplantation-centers-registry
#20
JOURNAL ARTICLE
Camilo Montero, Rodolfo Torres, Carlos Benavidez, Paola Garcia, Sandra Jimenez, Nancy Yomayusa, Diana Gayon, Jorge Perez, Diego Rosselli, Hector Restrepo, Carlos Alvarez-Moreno
BACKGROUND: The impact of immunosuppression in solid organ transplant recipients with SARS-CoV-2 infection is unknown. The knowledge about the behavior of different immunosuppression schemes in clinical outcomes is scarce. This study aimed to determine the risk of death in kidney transplant recipients with COVID-19 under two different schemes of immunosuppression. METHODS: We describe our experience in kidney transplant recipients with SARS-CoV-2 infection in seven transplant centers during the first year of the pandemic before starting the vaccination programs in the city of Bogotá...
January 19, 2023: Nefrología
keyword
keyword
120540
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.